RESUMEN
HLA-C*02 246 has one nucleotide change from HLA-C*02:02:02:01 at nucleotide 523 changing Arginine to Cysteine at residue 151.
Asunto(s)
Alelos , Secuencia de Bases , Exones , Antígenos HLA-C , Prueba de Histocompatibilidad , Humanos , Antígenos HLA-C/genética , Análisis de Secuencia de ADN/métodos , Alineación de Secuencia , Sustitución de Aminoácidos , CodónRESUMEN
HLA-A*11:463 has one nucleotide change from HLA-A*11:01:01:01 at nucleotide 508 changing Lysine (146) to Glutamine.
Asunto(s)
Antígenos HLA-A , Nucleótidos , Humanos , Masculino , Secuencia de Bases , Alelos , Antígenos HLA-A/genética , China , Padre , Análisis de Secuencia de ADNRESUMEN
HLA-C*01:02:86 has one synonymous nucleotide C > T change from HLA-C*01:02:01:01 at nucleotide 879 (residue 269 Proline).
Asunto(s)
Pueblos del Este de Asia , Antígenos HLA-C , Humanos , Secuencia de Bases , Antígenos HLA-C/genética , Alelos , Análisis de Secuencia de ADN , NucleótidosRESUMEN
HLA-C*01:212 differs from HLA-C*01:02:01:01 by two non-synonmous nucleotide changes at positions 368 and 379 in exon 3.
Asunto(s)
Pueblo Asiatico , Antígenos HLA-C , Alelos , China , Exones/genética , Antígenos HLA-C/genética , Humanos , Análisis de Secuencia de ADNRESUMEN
HLA-B*13:157 has one nucleotide change from HLA-B*13:02:01:01 at nucleotide 323 changing Tyrosine to Phenylalanine at residue 84.
Asunto(s)
Antígenos HLA-B , Nucleótidos , Alelos , Secuencia de Bases , Antígenos HLA-B/genética , Prueba de Histocompatibilidad , Humanos , Análisis de Secuencia de ADNRESUMEN
HLA-C*15:244 has one nucleotide change from HLA-C*15:05:01:01 at nucleotide 308 changing Arginine to Glutamine at residue 79.
Asunto(s)
Genes MHC Clase I , Antígenos HLA-C , Alelos , Secuencia de Bases , Antígenos HLA-C/genética , Humanos , Nucleótidos , Análisis de Secuencia de ADNRESUMEN
HLA-B*35:251:02 has one nucleotide change from HLA-B*35:22:01:01 at nucleotide 363 changing Serine to Arginine at residue 97.
Asunto(s)
Genes MHC Clase I , Antígenos HLA-B , Alelos , Secuencia de Bases , Antígenos HLA-B/genética , Prueba de Histocompatibilidad , Humanos , Nucleótidos , Análisis de Secuencia de ADNRESUMEN
HLA-B*40:482 has one nucleotide change from HLA-B*40:06:01:01 at nucleotide 430 changing glycine to arginine at residue 120.
Asunto(s)
Antígenos HLA-B , Nucleótidos , Alelos , Secuencia de Bases , Antígenos HLA-B/genética , Humanos , Análisis de Secuencia de ADNRESUMEN
HLA-A*11:398 has one nonsynonymous nucleotide change from HLA-A*11:01:01:01 at nucleotide 709, changing Isoleucine 213 to Valine.
Asunto(s)
Antígenos HLA-A , Nucleótidos , Alelos , Secuencia de Bases , China , Antígenos HLA-A/genética , Humanos , Análisis de Secuencia de ADNRESUMEN
One nucleotide replacement at position 728 of HLA-A*02:07:01 results in a novel allele, HLA-A*02:981.
Asunto(s)
Antígenos HLA-A , Alelos , Antígenos HLA-A/genética , Humanos , Análisis de Secuencia de ADNRESUMEN
HLA-A*24:516 has one nucleotide change from HLA-A*24:02:01:01 at nucleotide 194 where Alanine (41) is changed to Glycine.
Asunto(s)
Antígenos HLA-A , Núcleo Familiar , Alelos , Secuencia de Bases , China , Exones/genética , Antígenos HLA-A/genética , Humanos , Nucleótidos , Análisis de Secuencia de ADNRESUMEN
HLA-A*30:170 has one nucleotide change from HLA-A*30:01:01:01 at nucleotide 755 where Threonine T (228) is changed to Methionine M.
Asunto(s)
Metionina , Nucleótidos , Alelos , Secuencia de Bases , Antígenos HLA-A/genética , Humanos , Análisis de Secuencia de ADNRESUMEN
HLA-A*11:361:02 has one nucleotide change from HLA-A*11:01:01:01 at nucleotide 486 where Methionine (138) is changed to Isoleucine.
Asunto(s)
Pueblo Asiatico , Antígenos HLA-A , Alelos , Pueblo Asiatico/genética , Secuencia de Bases , China , Antígenos HLA-A/genética , Humanos , Análisis de Secuencia de ADNRESUMEN
In the present article, three kinds of metal-organic coordination compounds were synthesized between 1,2-trans-(4-pyridyl)ethene (dpe) and sulfate of Cu(II), Zn(II) and Cd(I) by hydrothermal reactions. Infrared, Raman and ultraviolet-visible spectra of dpe and its metal--organic complexes were studied. Assignments of the main FTIR and Raman bands were done in detail. The relationship between these characteristic bands and the structure of ligands and coordination compounds was discussed. In the FTIR spectra, the co-vibration absorption band of C-C and C-N for dpe shifts to the higher wavenumbers for three metal-organic coordination compounds, respectively. In the Raman spectra, the corresponding vibration bands of C-N, C=C, C-C and C-H were also observed to shift to higher wavenumbers. In the UV-visible absorption spectra, Zn-dpe and Cd-dpe has an absorption peak which could be attributed to the ligand absorption itself. However, two absorption peaks were observed for the complex of Cu-dpe, which were ascribed to the ligand absorption band and d-d electronic transition in the coordination compound. This indicates that there is a great change in the absorption spectra for the same ligand but with different metal ions.
RESUMEN
In the present article, two kinds of metal-organic coordination compounds were synthesized between 4-mercaptopyridine (4-MPy) and nitrate of Ag(I) and Cd(II) by a general solution reaction and evaporation. 4-mercaptopyridine and two transition metal complexes were investigated by means of infrared, Raman and ultraviolet-visible spectroscopic techniques, respectively. Assignments of the main FTIR and Raman bands were carried out in detail. The relationship between those characteristic bands and the structure of ligands and coordination compounds was discussed. In the FTIR spectra, the co-vibration absorption band of nu(C==C) and nu(C==N), for 4-MPy at 1 459 cm(-1) blue-shifted to 1 464 cm(-1) for both the metal-organic coordination compounds, respectively. The Raman spectra, for the two coordination compounds, at 1 004 and 1 008 cm(-1), which can be assigned to ring breathing vibration, at 1 617 and 1 615 cm ', which can be assigned to ring flex vibration, and at 720 and 720 cm(-1), which can be assigned to the composite vibration of beta(C--C) and nu(C--S) are similar, respectively.